Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Lannett Company (LCI) stocks in Canada

Learn how to easily invest in Lannett Company stocks.

Lannett Company is a drug manufacturers-specialty & generic business based in the US. Lannett Company stocks (LCI.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $4.74 – an increase of 2.04% over the previous week. Lannett Company employs 810 staff and has a trailing 12-month revenue of around $372.4 million.

How to buy stocks in Lannett Company

  1. Compare stock trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – LCI – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of stocks with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Lannett Company stock price (NYSE:LCI)

Use our graph to track the performance of LCI stocks over time.

Lannett Company shares at a glance

Information last updated 2022-05-27.
Latest market close$0.50
52-week range$0.45 - $5.82
50-day moving average $0.68
200-day moving average $1.75
Wall St. target price$2.25
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-7.89

Compare stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 6 of 6
Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
CIBC Investor's Edge
Finder Rating:
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Young investors 18 to 24 can get free online trades and a $0 annual account fee. Conditions apply.
Wealthsimple Trade
Finder Rating:
3.9 / 5
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
3.8 / 5
$4.99 - $9.99
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
4.1 / 5
Min. $1.00, Max. 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get almost $500 in commission free trades when you fund your new account with a minimum of $10,000. Conditions apply. Ends August 31, 2022.

Compare up to 4 providers

Online stock trading

Is it a good time to buy Lannett Company stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Lannett Company price performance over time

Historical closes compared with the close of $0.5 from 2022-05-27

1 week (2022-05-18) N/A
1 month (2022-04-29) -21.88%
3 months (2022-03-01) -40.48%
6 months (2021-11-29) -69.70%
1 year (2021-05-28) -88.37%
2 years (2020-05-29) -93.46%
3 years (2019-05-29) 5.5
5 years (2017-05-26) 20.05

Is Lannett Company under- or over-valued?

Valuing Lannett Company stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Lannett Company's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Lannett Company's EBITDA

Lannett Company's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $9.9 million.

The EBITDA is a measure of a Lannett Company's overall financial performance and is widely used to measure a its profitability.

Lannett Company financials

Revenue TTM $372.4 million
Gross profit TTM $100.4 million
Return on assets TTM -4.46%
Return on equity TTM -18622.01%
Profit margin -84.91%
Book value $3.14
Market capitalisation $21.5 million

TTM: trailing 12 months

Lannett Company share dividends

We're not expecting Lannett Company to pay a dividend over the next 12 months.

Have Lannett Company's shares ever split?

Lannett Company's shares were split on a 3:2 basis on 2 March 2003. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Lannett Company shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Lannett Company shares which in turn could have impacted Lannett Company's share price.

Lannett Company share price volatility

Over the last 12 months, Lannett Company's shares have ranged in value from as little as $0.451 up to $5.82. A popular way to gauge a stock's volatility is its "beta".

LCI.US volatility(beta: 1.17)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Lannett Company's is 1.1732. This would suggest that Lannett Company's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Lannett Company overview

Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual, suspensions, soft gel, injectable, and oral dosages. It also provides its products for various medical indications, such as analgesic, anti-psychosis, cardiovascular, central nervous system, endocrinology, gastrointestinal, infectious disease, migraine, respiratory/allergy/cough/cold, urinary, and others medical indications. The company's primary products include Levothyroxine Sodium tablets, Fluphenazine tablets, Posaconazole DR tablets, Verapamil SR tablets, Methylphenidate CD capsules, Omeprazole capsules, Pantoprazole Sodium DR tablets, Sumatriptan Nasal spray, Metolazone tablets, Amphetamine IR Tablets, Methylphenidate Hydrochloride ER stimulants, as well as cocaine hydrochloride solution. It sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical companies, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with Summit Bioscience LLC, HEC Group of companies, Dexcel Pharma, Elite Pharmaceuticals, RivoPharm, and various other companies.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site